{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "9924842", "DateCompleted": {"Year": "1999", "Month": "03", "Day": "29"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0279-1072", "JournalIssue": {"Volume": "30", "Issue": "4", "PubDate": {"Year": "1998", "Season": "Oct-Dec"}}, "Title": "Journal of psychoactive drugs", "ISOAbbreviation": "J Psychoactive Drugs"}, "ArticleTitle": "Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions.", "Pagination": {"StartPage": "367", "EndPage": "369", "MedlinePgn": "367-9"}, "Abstract": {"AbstractText": ["The Amazonian psychoactive plant beverage ayahuasca has attracted increasing interest in recent years. Little attention has been given, however, to potentially dangerous interactions with other drugs. In particular, the interaction between the potent monoamine oxidase-inhibiting harmala alkaloids in ayahuasca and the selective serotonin reuptake inhibitor (SSRI) class of antidepressants may induce a serotonin syndrome with potentially grave outcome. Caution is advised when combining ayahuasca with certain pharmaceutical drugs."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, University of Kuopio, Finland."}], "Identifier": [], "LastName": "Callaway", "ForeName": "J C", "Initials": "JC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Grob", "ForeName": "C S", "Initials": "CS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Psychoactive Drugs", "NlmUniqueID": "8113536", "ISSNLinking": "0279-1072"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Serotonin Uptake Inhibitors"}, {"RegistryNumber": "01K63SUP8D", "NameOfSubstance": "Fluoxetine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Brazil"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Fluoxetine"}, {"QualifierName": [], "DescriptorName": "Herb-Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["adverse effects", "chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemically induced", "psychology"], "DescriptorName": "Serotonin Syndrome"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Selective Serotonin Reuptake Inhibitors"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "1", "Day": "30"}, {"Year": "1999", "Month": "1", "Day": "30", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "1", "Day": "30", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9924842", "10.1080/02791072.1998.10399712"]}}], "PubmedBookArticle": []}